Elisa Galvez

1PUBLICATIONS
7CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Apr 08, 2026
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.

Yvette Drew, Lucy Gilbert, Alejandro Martinez Bueno

Pageof 1

Frequent Collaborators

1 joint publications

Yvette Drew

1 joint publications

Ana Oaknin

1 joint publications

Victor Moreno

1 joint publications

Rebecca S Kristeleit